Health · 22 views
Cannabis-derived treatment eases agitation in hospice-eligible dementia patients, trial finds
In a first-of-its-kind clinical trial, U.S. researchers found that people with agitation and dementia in late life who took a special medical formulation of two active ingredients found in marijuana—THC and CBD—had significantly less agi…
AI Summary
Researchers have conducted a clinical trial involving patients with dementia and agitation, a condition often seen in those nearing hospice eligibility. The trial involved administering a medical formulation containing THC and CBD, two active ingredients found in marijuana, to patients with agitation and dementia. The results showed that patients receiving this formulation experienced significantly less agitation compared to those who received a placebo.
AI summaries can be wrong sometimes—always verify important details using the source article.
How AI & Automation are usedMore from Health
Continue reading recent Health coverage
- New framework boosts the accuracy of disease risk prediction from genetic dataContinue reading
- Small bowel microbiome offers clues to women's healthContinue reading
- Why do I crash at 3pm? The science behind the 'afternoon slump'Continue reading
- CBD may fall short in treating alcohol use disorder, despite promising animal studiesContinue reading
Support HappeningNow
Independent AI-powered news analysis is reader-supported. Your contribution helps cover infrastructure, summaries, and continued platform development.
Support HappeningNow